SCHEMBL17367156

SCHEMBL17367156

c1ccc(-n2c3ccccc3c3c4ccc5c6c7ccccc7ccc6n(-c6ccccc6)c5c4sc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 3/20 0.33
RAB9A P51151 2/20 0.33
MAPK1 P28482 2/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP1A1 P04798 1/20 0.32
CYP1B1 Q16678 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
USP2 O75604 1/20 0.31
ALOX15 P16050 1/20 0.31
APOBEC3A P31941 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367073 0.90 L3MBTL1 (0.41) ATML3MBTL1KDM4EHSD17B10RAB9A
SCHEMBL17367159 0.87 L3MBTL1 (0.41) ATML3MBTL1KDM4EHSD17B10RAB9A
SCHEMBL17367129 0.85 L3MBTL1 (0.52) ATML3MBTL1KDM4EHSD17B10MAPK1
SCHEMBL17366914 0.84 ALDH1A1 (0.38) ATML3MBTL1KDM4EHSD17B10MAPK1
SCHEMBL25681028 0.84 PRNP (0.35) ATML3MBTL1KDM4EHSD17B10RAB9A
SCHEMBL17989790 0.84 L3MBTL1 (0.50) ATML3MBTL1KDM4EHSD17B10RAB9A
SCHEMBL15126974 0.83 HSD17B10 (0.34) ATML3MBTL1KDM4EHSD17B10RAB9A
SCHEMBL17367107 0.82 KDM4E (0.41) ATML3MBTL1KDM4EHSD17B10RAB9A
SCHEMBL11914274 0.82 L3MBTL1 (0.52) ATML3MBTL1KDM4EHSD17B10RAB9A
SCHEMBL13789874 0.82 L3MBTL1 (0.44) ATML3MBTL1KDM4EHSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 ATM 3202/4885L3MBTL1 717/4885KDM4E 3404/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 ATM 3202/4885L3MBTL1 717/4885KDM4E 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.